Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts

Clinical trial NCT04467671 · RECRUITING

Trial details

NCT number: NCT04467671
Sponsor: Nationwide Children's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HLH - Hypoplastic Left Heart Syndrome DORV DILV - Double Inlet Left Ventricle Mitral Atresia Tricuspid Atresia Unbalanced AV Canal Single-ventricle Heart Defects, Congenital Cardiovascular Abnormalities Cardiovascular Diseases Heart Diseases

Start date: 2020-07-15
Primary completion: 2026-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.